BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19415766)

  • 1. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells.
    Senju S; Haruta M; Matsunaga Y; Fukushima S; Ikeda T; Takahashi K; Okita K; Yamanaka S; Nishimura Y
    Stem Cells; 2009 May; 27(5):1021-31. PubMed ID: 19415766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype.
    Goodridge HS; Marshall FA; Wilson EH; Houston KM; Liew FY; Harnett MM; Harnett W
    Immunology; 2004 Dec; 113(4):491-8. PubMed ID: 15554927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human iPS Cell-Derived Germ Cells: Current Status and Clinical Potential.
    Ishii T
    J Clin Med; 2014 Oct; 3(4):1064-83. PubMed ID: 26237592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPS cells generation: an overview of techniques and methods.
    Telpalo-Carpio S; Aguilar-YaƱez J; Gonzalez-Garza M; Cruz-Vega D; Moreno-Cuevas J
    J Stem Cells Regen Med; 2013; 9(1):2-8. PubMed ID: 24693202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy.
    Senju S; Haruta M; Matsumura K; Matsunaga Y; Fukushima S; Ikeda T; Takamatsu K; Irie A; Nishimura Y
    Gene Ther; 2011 Sep; 18(9):874-83. PubMed ID: 21430784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions.
    van Wilgenburg B; Browne C; Vowles J; Cowley SA
    PLoS One; 2013; 8(8):e71098. PubMed ID: 23951090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease.
    Jiang Y; Cowley SA; Siler U; Melguizo D; Tilgner K; Browne C; Dewilton A; Przyborski S; Saretzki G; James WS; Seger RA; Reichenbach J; Lako M; Armstrong L
    Stem Cells; 2012 Apr; 30(4):599-611. PubMed ID: 22311747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [iPS-cell derived dendritic cells and macrophages for cancer therapy].
    Senju S
    Rinsho Ketsueki; 2016 Aug; 57(8):1074-9. PubMed ID: 27599426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent stem cells as source of dendritic cells for immune therapy.
    Senju S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Fukushima S; Matsuyoshi H; Nishimura Y
    Int J Hematol; 2010 Apr; 91(3):392-400. PubMed ID: 20155337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells in medicine and biology.
    Takahashi K; Yamanaka S
    Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions.
    Yanagimachi MD; Niwa A; Tanaka T; Honda-Ozaki F; Nishimoto S; Murata Y; Yasumi T; Ito J; Tomida S; Oshima K; Asaka I; Goto H; Heike T; Nakahata T; Saito MK
    PLoS One; 2013; 8(4):e59243. PubMed ID: 23573196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Human-Induced Pluripotent Stem Cells to Macrophages for Disease Modeling and Functional Genomics.
    Shi J; Xue C; Liu W; Zhang H
    Curr Protoc Stem Cell Biol; 2019 Feb; 48(1):e74. PubMed ID: 30537374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.
    Themeli M; Kloss CC; Ciriello G; Fedorov VD; Perna F; Gonen M; Sadelain M
    Nat Biotechnol; 2013 Oct; 31(10):928-33. PubMed ID: 23934177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
    Minagawa A; Yoshikawa T; Yasukawa M; Hotta A; Kunitomo M; Iriguchi S; Takiguchi M; Kassai Y; Imai E; Yasui Y; Kawai Y; Zhang R; Uemura Y; Miyoshi H; Nakanishi M; Watanabe A; Hayashi A; Kawana K; Fujii T; Nakatsura T; Kaneko S
    Cell Stem Cell; 2018 Dec; 23(6):850-858.e4. PubMed ID: 30449714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges.
    Yamanaka S
    Cell Stem Cell; 2020 Oct; 27(4):523-531. PubMed ID: 33007237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells.
    Kitadani J; Ojima T; Iwamoto H; Tabata H; Nakamori M; Nakamura M; Hayata K; Katsuda M; Miyajima M; Yamaue H
    Sci Rep; 2018 Mar; 8(1):4569. PubMed ID: 29545628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor immune response of dendritic cells (DCs) expressing tumor-associated antigens derived from induced pluripotent stem cells: in comparison to bone marrow-derived DCs.
    Iwamoto H; Ojima T; Hayata K; Katsuda M; Miyazawa M; Iida T; Nakamura M; Nakamori M; Iwahashi M; Yamaue H
    Int J Cancer; 2014 Jan; 134(2):332-41. PubMed ID: 23824921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future prospects for cancer immunotherapy using induced pluripotent stem cell-derived dendritic cells or macrophages.
    Fukushima S; Miyashita A; Kuriyama H; Kimura T; Mizuhashi S; Kubo Y; Nakahara S; Kanemaru H; Tsuchiya N; Mashima H; Zhang R; Uemura Y
    Exp Dermatol; 2023 Mar; 32(3):290-296. PubMed ID: 36529534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
    Iriguchi S; Yasui Y; Kawai Y; Arima S; Kunitomo M; Sato T; Ueda T; Minagawa A; Mishima Y; Yanagawa N; Baba Y; Miyake Y; Nakayama K; Takiguchi M; Shinohara T; Nakatsura T; Yasukawa M; Kassai Y; Hayashi A; Kaneko S
    Nat Commun; 2021 Jan; 12(1):430. PubMed ID: 33462228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.